119 related articles for article (PubMed ID: 38820971)
1. Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers.
Su PC; Chen CY; Yu MH; Kuo IY; Yang PS; Hsu CH; Hou YC; Hsieh HT; Chang CP; Shan YS; Wang YC
Biomed Pharmacother; 2024 Jul; 176():116825. PubMed ID: 38820971
[TBL] [Abstract][Full Text] [Related]
2. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
Kawada M; Seno H; Kanda K; Nakanishi Y; Akitake R; Komekado H; Kawada K; Sakai Y; Mizoguchi E; Chiba T
Oncogene; 2012 Jun; 31(26):3111-23. PubMed ID: 22056877
[TBL] [Abstract][Full Text] [Related]
3. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer.
Watanabe K; Shiga K; Maeda A; Harata S; Yanagita T; Suzuki T; Ushigome H; Maeda Y; Hirokawa T; Ogawa R; Hara M; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913066
[TBL] [Abstract][Full Text] [Related]
4. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
[No Abstract] [Full Text] [Related]
5. Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
Patel SP; Bristol A; Saric O; Wang XP; Dubeykovskiy A; Arlen PM; Morse MA
Cancer Immunol Immunother; 2013 Jun; 62(6):1011-9. PubMed ID: 23591984
[TBL] [Abstract][Full Text] [Related]
6. Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries.
Kang K; Kim K; Lee SR; Kim Y; Lee JE; Lee YS; Lim JH; Lim CS; Kim YJ; Baek SI; Song DH; Hong JT; Kim DY
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32883029
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
8. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
9. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
[No Abstract] [Full Text] [Related]
10. A humanized Anti-YKL-40 antibody inhibits tumor development.
Yu H; Wang Z; Zhu B; Jia Z; Luo J; Han X; Chen H; Shao R
Biochem Pharmacol; 2024 Jul; 225():116335. PubMed ID: 38824968
[TBL] [Abstract][Full Text] [Related]
11. Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine.
Xavier CPR; Castro I; Caires HR; Ferreira D; Cavadas B; Pereira L; Santos LL; Oliveira MJ; Vasconcelos MH
Cancer Lett; 2021 Mar; 501():210-223. PubMed ID: 33212158
[TBL] [Abstract][Full Text] [Related]
12. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
[TBL] [Abstract][Full Text] [Related]
13. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Dineen SP; Sullivan LA; Beck AW; Miller AF; Carbon JG; Mamluk R; Wong H; Brekken RA
BMC Cancer; 2008 Nov; 8():352. PubMed ID: 19038046
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
15. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers.
Faibish M; Francescone R; Bentley B; Yan W; Shao R
Mol Cancer Ther; 2011 May; 10(5):742-51. PubMed ID: 21357475
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells.
Yang X; Fang D; Li M; Chen J; Cheng Y; Luo J
Med Sci Monit; 2021 Mar; 27():e929431. PubMed ID: 33764958
[TBL] [Abstract][Full Text] [Related]
17. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
[TBL] [Abstract][Full Text] [Related]
18. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer.
Aikawa T; Gunn J; Spong SM; Klaus SJ; Korc M
Mol Cancer Ther; 2006 May; 5(5):1108-16. PubMed ID: 16731742
[TBL] [Abstract][Full Text] [Related]
20. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse Model.
Zhao Y; Wang J; Liu WN; Fong SY; Shuen TWH; Liu M; Harden S; Tan SY; Cheng JY; Tan WWS; Chan JKY; Chee CE; Lee GH; Toh HC; Lim SG; Wan Y; Chen Q
Hepatology; 2021 Sep; 74(3):1395-1410. PubMed ID: 33738839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
